Investigational new drugGLP-1
Compound 61636
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061636
Risk Class
MODERATE
Last Audit
May 18, 2108
Research Abstract
GLP-1 candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61636 is a glp-1 asset inside glp-1 innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in investigational new drug with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061636 with updates logged 2108-05-18.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61636GLP-1 Program 61636
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061636
- [2] Operations Pulse • GLP-1 innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61636